Theranostics by testing CFTR modulators in patient-derived materials: the current status and a proposal for subjects with rare CFTR mutations
Inhaled antibiotic use is associated with Scedosporium/Lomentospora species isolation in cystic fibrosis
Rate of Uptake of Ivacaftor Use after U.S. Food and Drug Administration Approval among Patients Enrolled in the U.S. Cystic Fibrosis Foundation Patient Registry
Do current clinical trials in cystic fibrosis match the priorities of patients and clinicans? A systematic review.
Non-fasting bioelectrical impedance analysis in cystic fibrosis: Implications for clinical practice and research
Supersonic Shear-Wave Elastography and APRI for the detection and staging of liver disease in paediatric cystic fibrosis
Blood Biomarkers to Predict Short-term Pulmonary Exacerbation Risk in Children and Adolescents with CF: A Pilot Study
GLPG1837, a CFTR potentiator, in p.Gly551Asp (G551D)-CF patients: An open-label, single-arm, phase 2a study (SAPHIRA1)
